Henry Schein, Inc. (NASDAQ:HSIC) Position Boosted by CIBC Asset Management Inc

CIBC Asset Management Inc grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 17,849 shares of the company’s stock after purchasing an additional 169 shares during the period. CIBC Asset Management Inc’s holdings in Henry Schein were worth $1,235,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in HSIC. Cromwell Holdings LLC boosted its position in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares in the last quarter. Versant Capital Management Inc boosted its holdings in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares during the period. Quent Capital LLC boosted its holdings in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after buying an additional 323 shares during the period. City State Bank acquired a new position in shares of Henry Schein in the fourth quarter worth about $55,000. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares during the period. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several recent analyst reports. Wells Fargo & Company initiated coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Barrington Research raised their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Thursday, January 30th. Finally, Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Price Performance

Shares of HSIC opened at $77.24 on Friday. The firm has a market cap of $9.63 billion, a PE ratio of 31.79, a PEG ratio of 2.13 and a beta of 0.91. The firm’s 50 day moving average price is $74.14 and its 200 day moving average price is $72.26. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.